Showing results (1-10 of 297) with videos related to
Sort By:
Pageof 30
Journal of Clinical Pharmacology|May 18, 2004
Optimizing dose selection with modeling and simulation: application to the vasopeptidase inhibitor M100240Marc Pfister, Nancy E Martin, Lloyd P Haskell, et al.Clinical Pharmacokinetics|May 25, 2005
Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapyJeffrey S Barrett, Line Labbé, Marc PfisterThe AAPS Journal|December 16, 2005
Modeling and simulation of adherence: approaches and applications in therapeuticsLeslie A Kenna, Line Labbé, Jeffrey S Barrett, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 20, 2010
Application of Individualized Bayesian Urea Kinetic Modeling to pediatric hemodialysisOlivera Marsenic, Liping Zhang, Athena Zuppa, et al.Journal of Clinical Pharmacology|November 17, 2004
The effect of food on the pharmacokinetics of a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240Iolanda Cirillo, Nancy E Martin, Barbara Brennan, et al.Journal of Clinical Pharmacology|March 31, 2004
No clinically relevant CYP3A induction with the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240Nancy E Martin, Stanley R Howell, Louis L Martin, et al.Clinical Pharmacokinetics|March 15, 2005
Pharmacodynamic analysis of the microbiological efficacy of telithromycin in patients with community-acquired pneumoniaJun Shi, Marc Pfister, Stephen G Jenkins, et al.Journal of Clinical Pharmacology|May 20, 2003
Pharmacoscintigraphic assessment of the regional drug absorption of the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240, in healthy volunteersNancy E Martin, Kathryn R Collison, Louis L Martin, et al.British Journal of Clinical Pharmacology|November 21, 2013
Paediatric models in motion: requirements for model-based decision support at the bedsideJeffrey S BarrettBritish Journal of Clinical Pharmacology|October 30, 2020
Risk assessment of therapeutic agents under consideration to treat COVID-19 in paediatric patients and pregnant womenJeffrey S BarrettPageof 30